Latest News about FDA
Recent news which mentions FDA
Horizon Therapeutics Begins Patient Enrolment in Phase 2 trial of Daxdilimab (HZN-7734) for Alopecia Areata
May 17, 2022
Tickers
HZNP
From Benzinga
From Benzinga
Nurix Therapeutics Doses First Patient in Phase 1a/1b Study of NX-5948 For B-cell malignancies
May 17, 2022
Tickers
NRIX
From Benzinga
From Benzinga
C4 Therapeutics Doses First Patient in Phase 1/2 Trial of CFT8634 For SMARCB1-perturbed cancers
May 16, 2022
Tickers
CCCC
From Benzinga
scPharmaceuticals Shares Are Trading High Following FDA's Acceptance of NDA for FUROSCIX
May 16, 2022
Tickers
SCPH
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.